News Daily News Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach Michael O'Riordan June 21, 2022
News Conference News EuroPCR 2022 MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients Michael O'Riordan May 20, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022
News Daily News FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor Shelley Wood February 22, 2022
News Conference News STS 2022 Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression Michael O'Riordan February 04, 2022
News Conference News STS 2022 Modified Surgical MV Repair Stands Up to Replacement Michael O'Riordan February 03, 2022
News Conference News THT 2022 LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety Caitlin E. Cox February 02, 2022
News Conference News THT 2022 Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size Shelley Wood February 02, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Daily News CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests Yael L. Maxwell December 13, 2021
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Conference News TCT 2021 GUIDE-HF Hints That Hemodynamic-Guided Management Works in HFpEF Michael O'Riordan November 06, 2021
News Daily News Cardiogenic Shock Teams May Lower Mortality in Cardiac ICUs Todd Neale September 21, 2021
News Conference News ESC 2021 SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI Michael O'Riordan August 27, 2021
News Conference News ESC 2021 GUIDE-HF: Pulmonary Artery Sensor May Help in Mild HF, but COVID-19 Muddies Water Shelley Wood August 27, 2021
News Conference News ACC 2021 Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF Michael O'Riordan May 25, 2021